Press Releases
Siemens Introduces Next-Generation Molecular Diagnostics Technology for HIV-1 Viral Load Testing
December 11, 2008
Erlangen, Germany, December 11, 2008 - Siemens Healthcare (www.siemens.com/diagnostics) received CE marking approval to sell the new VERSANT kPCR Molecular System and the VERSANT HIV-1 RNA 1.0 Assay (kPCR) for monitoring the viral load of HIV-1 infected patients who are undergoing antiviral therapy. Viral load testing measures the plasma levels of the virus, which is critical when monitoring and guiding patients’ HIV therapy. More
New Patient Study Suggests Siemens Non-Invasive Blood Test May Have a Role in Monitoring Breast Cancer Patients’ Response to Herceptin*(trastuzumab) Therapy
November 17, 2008
Deerfield, Ill., November 17, 2008 - Siemens Healthcare (www.siemens.com/diagnostics) announced that data from a new study published in the American Cancer Society journal Cancer, supports using the Siemens Serum HER-2/neu test to monitor patients with an aggressive type of metastatic breast cancer. This non-invasive blood test can be used to help monitor the widely-used Herceptin® therapy. More
Siemens Molecular Testing System has New Operating System
November 10, 2008
Deerfield, Ill., November 10, 2008 - Siemens Healthcare (www.siemens.com/diagnostics) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use of its new Apple iMac OSX operating system to support the company’s TRUGENE® HIV-1 Genotyping Kit and the OpenGene® DNA Sequencing System. The new operating system benefits the molecular testing needs of laboratory customers by increasing patient data storage, expanding patient data management capabilities, accelerating sequencing capabilities and advancing customized reporting functionalities. More
SIEMENS COMPLETES HEPATITIS B TEST PANEL FOR THE HIGH-VOLUME LABORATORY AND INTRODUCES HEPATITIS B TESTING TO THE MID-VOLUME LABORATORY
July 2, 2008
DEERFIELD, Ill. July 2, 2008 - Siemens Healthcare Diagnostics received CE marking approval to sell the hepatitis B virus e-antigen (HBeAg) and antibody to the hepatitis B virus (anti-HBe) tests in the European marketplace. More
PREMIER HEALTHCARE ALLIANCE HONORS SIEMENS HEALTHCARE DIAGNOSTICS FOR EXCELLENCE IN SUPPLIER PERFORMANCE
June 23, 2008
MALVERN, Pa., June 23, 2008 - The Premier healthcare alliance Purchasing Partners division recently announced that Siemens Healthcare Diagnostics (www.siemens.com/diagnostics) was one of 15 winners chosen for the Pinnacle Award out of more than 800 eligible suppliers, representing the top two percent of healthcare equipment suppliers. More
SIEMENS AND LABCORP ENTER AGREEMENT TO CO-DEVELOP NEW CLINICAL DIAGNOSTIC TESTS
May 8, 2008
DEERFIELD, IL. May 8, 2008 - Siemens Healthcare and Laboratory Corporation of America® Holdings (LabCorp®) today announced that they have entered a non-exclusive agreement to discuss future possibilities to co-develop new clinical diagnostic tests in the areas of companion diagnostics, metabolic syndrome, oncology and diabetes. More
DONAL QUINN HEADS DIAGNOSTICS DIVISION OF SIEMENS’ HEALTHCARE SECTOR
May 6, 2008
Donal Quinn has been appointed new head of the Diagnostics division of the Siemens Healthcare Sector. In his new position, Quinn succeeds Jim Reid-Anderson, who on May 1st became the new CEO of this sector. Prior to his new job, Quinn served as Executive Vice President and Chief Customer Officer of the Diagnostics division since November 2007. More
SIEMENS RECEIVES FDA APPROVAL FOR THE VERSANT 440 MOLECULAR SYSTEM
February 18, 2008
DEERFIELD, IL., Feb. 18, 2008 ― Siemens Healthcare (www.siemens.com/diagnostics) announced today that its VERSANT™ 440 Molecular System has been approved for marketing by the U.S. Food and Drug Administration (FDA) for use with the VERSANT HCV RNA 3.0 assay for management of HCV-infected patients undergoing antiviral therapy. More
SIEMENS HEALTHCARE DIAGNOSTICS LAUNCHES B12, FOLATE, AND FERRITIN TESTS ON ITS DIMENSION VISTA INTELLIGENT LAB SYSTEM
January 16, 2008
Deerfield, IL, January 16, 2008 Siemens Healthcare Diagnostics, today announced that it has launched the LOCI® Folate, LOCI® B12, and LOCI® Ferritin tests for use on the Dimension Vista® 1500 Intelligent Lab System, an ultra-integrated chemistry analyzer More
SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS INTRODUCES MICROSCAN WALKAWAY PLUS MICROBIOLOGY SYSTEMS
December 20, 2007
DEERFIELD, IL, Dec. 20, 2007 – Siemens Medical Solutions Diagnostics today announced the introduction of the MicroScan® WalkAway® plus Systems for mid- and high-volume clinical diagnostic microbiology laboratories. More
